HOME >> BIOLOGY >> NEWS
Clinical trial data regarding NKTR-061 will be presented at ATS International Conference

San Francisco, Calif. -- Results of a Phase 2a clinical trial evaluating the potential of NKTR-061 (inhaled amikacin) to treat hospital acquired gram-negative bacterial pneumonia will be presented at the American Thoracic Society (ATS) International Conference, May 18 23, 2007, in San Francisco.

WHO: Dr. Michael S. Niederman, MD, Chairman, Department of Medicine, Winthrop-University Hospital, Professor of Medicine; Vice Chairman, Department of Medicine, SUNY at Mineoloa.

Dr. Jean Chastre, Professor of Medicine, University of Paris.

WHAT: Four posters detailing the results of a Phase 2a clinical trial evaluating the pharmacokinetic, serum and tracheal aspirate concentration, safety and antibiotic reduction properties of NKTR-061.

Data will be presented and discussed at this ATS session to show a reduction in the use of IV antibiotics in mechanically ventilated patients during treatment of gram-negative pneumonia with NKTR-061. Further, the data indicate that the administration of NKTR-061 resulted in high tracheal aspirate concentrations and high epithelial lining fluid concentrations of amikacin in gram-negative pneumonia in intubated mechanically ventilated patients. Finally, data will be presented indicating that NKTR-061 achieves safe serum concentrations following multiple dosing in intubated mechanically ventilated patients with gram-negative pneumonia.

WHEN: Monday, May 21st, 2007, 8:15-11:00 am (PT)

WHERE: The American Thoracic Society (ATS) International Conference at the San Francisco Marriott Hotel.

ABOUT NKTR-061:

NKTR-061 (inhaled amikacin) is being tested to evaluate the safety and tolerability of amikacin formulated for inhalation for the adjunctive treatment of gram-negative pneumonia in ventilated patients diagnosed with hospital or ventilator associated pneumonia. This new inhaled antibiotics product candidate leverages N
'"/>

Contact: Tim Warner
twarner@nektar.com
650-283-4915
Nektar Therapeutics
9-May-2007


Page: 1 2

Related biology news :

1. 2007-2008 Genzyme/ACMGF Clinical Genetics Fellowship In Biochemical Genetics award winner announced
2. Scientists honored with Excellence in Clinical Research Award
3. Clinical trial for diabetic macular edema
4. The Parkinsons Institute to conduct Phase III Clinical Trial of creatine for Parkinsons disease
5. Research and program highlights of the 2007 Annual Clinical Genetics Meeting, March 21-25, 2007
6. American College of Medical Genetics -- 2007 Annual Clinical Genetics Meeting Announcement
7. October MCP: A special issue on Clinical Proteomics
8. Columbia University Medical Center receives major new NIH Clinical Science investment funds
9. Researchers reverse juvenile diabetes in animal model; Clinical trial FDA approved
10. Clinical trial to test stem cell approach for children with brain injury
11. Vaccine trials inject hope into koalas future

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/7/2020)... ... January 06, 2020 , ... Myant Inc. , the pioneers ... Vegas) to bring to life its vision of a world where textile-based interfaces knitted ... the AI-powered digital sphere, and the physical IoT-enabled environment. The experience at Myant’s booth ...
(Date:12/30/2019)... SAN DIEGO (PRWEB) , ... December 30, 2019 , ... ... cooking events company has seen its highest sales in 2019, having hosted a multitude ... and Illumina, have all visited the company’s La Jolla-based venue, and the company has ...
(Date:12/18/2019)... ... December 17, 2019 , ... EconoFact, a non-profit media initiative ... Fletcher School, Tufts University, is pleased to announce a collaboration with Macmillan Learning ... using Macmillan Learning’s acclaimed series of economics textbooks. , Under the agreement, Macmillan ...
Breaking Biology News(10 mins):
(Date:1/8/2020)... ... 08, 2020 , ... Anomet Products has introduced ... use in harsh environments inside or outside of the human body. , ... alloys to achieve specific properties such as corrosion-resistance, biocompatibility, or operation at temperatures ...
(Date:1/7/2020)... ... 07, 2020 , ... Vuja De Sciences (“Vuja De”), a biotechnology startup dedicated ... appointments of Chand Khanna, DVM, PhD, DACVIM (Onc), and Dr. Lee Helman, MD, to ... are delighted to welcome Chand and Lee as new directors. They will be of ...
(Date:1/7/2020)... ... January 06, 2020 , ... ABCT ... emerging biosciences ventures invited to participate in the annual program. Twelve ventures will ... plans and a professional network. All startups will receive an entrepreneur coach, access ...
(Date:12/30/2019)... ... December 30, 2019 , ... Leak ... instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries is pleased ... 11 compliant software program specific to the custom-built helium leak testing systems it ...
Breaking Biology Technology:
Cached News: